In our previous published work13, we discovered several urinary glycopeptides, for instance, FLN*ESYK from ACPP (where * indicated the glycosylation site) and EDALN*ETR from CLU, as candidate markers for detecting aggressive PCa which can serve as adjuncts to serum PSA test. Here, ACP3 is linked to posterior cortical atrophy.